Objectives: This publication reports the EAO Workshop group-2 discussions and consensus statements which provided the scientific evidence on the influence of biological parameters on implant-related clinical outcomes.
| INTRODUC TI ON

| Biological effect of abutment material on the stability of peri-implant marginal bone levels. Systematic review and meta-analysis
Peri-implant health, including peri-implant marginal bone levels, may be influenced by abutment materials. The standard abutment material for many years has been titanium, but for suggested improved aesthetic outcomes and tissue tolerance new materials have been introduced. The evaluated systematic review has assessed the scientific evidence of possible biological effects of different abutment materials on peri-implant hard and soft tissues.
The main goal of this systematic review was to compare alternative materials to titanium using controlled clinical trials, including RCTs and CCTs (Sanz-Sánchez, Sanz-Martín, Carrillo de Albornoz, Figuero, & Sanz, 2018) . The review was supplemented with prospective case series focusing exclusively on these different materials. The primary outcome was changes in marginal bone levels.
Secondary outcomes were:
• implant survival or success.
• peri-implant diagnostic parameters: probing depth, gingival and bleeding index, plaque index.
• aesthetics: peri-implant soft tissue level, dimension of keratinized mucosa, colour of the mucosa, any aesthetic index.
• complications: biological and technical.
• patient-reported outcome measures (PROMs).
The systematic review included 29 investigations, from which 15 were RCTs, five CCTs and nine case series. The study material included 954 patients (1,266 implants) with a mean follow-up period of 30.05 months (range: 6-86.4 months).
Sufficient data were available to perform meta-analyses of the primary outcome and a limited number of secondary outcomes (probing depth, bleeding index, plaque index and technical complications).
| CONS ENSUS S TATEMENTS
| Which abutment materials have been used in clinical studies?
Based on 20 clinical trials (5 CCTs and 15 RCTs), the most common test abutment material used was zirconia (n = 13) followed by alumina (n = 5), gold (n = 3), lithium disilicate (n = 1) and the combination of nickel with titanium (n = 1) and zirconia with ceramic (n = 1).
In control groups, titanium was used most frequently (n = 14), followed by zirconia (n = 3), lithium disilicate (n = 1) and alumina (n = 1).
Two of these 20 clinical trials demonstrated low risk of bias for six items based on the Cochrane Collaboration Recommendations. Three studies had a low risk of bias for five criteria. The remaining studies had a high or unclear risk of bias in two or more criteria.
Among the nine case series, zirconia (n = 5), alumina (n = 2), titanium nitride (n = 1) and a compound material made of zirconia and alumina (n = 1) were used as abutment materials. Only 1 study met the 4 quality categories (Newcastle-Ottawa Scale). 
|
| What is the effect of abutment materials on implant survival?
Based on 28 studies (14 RCTs, five CCTs and nine case series), mean implant survival was 99.2% (range: 89%-100%).
In the controlled studies, no significant differences were found between test and control groups (98.8% and 99.4%, respectively). 
|
| Bleeding on probing
Based on six randomized clinical trials, no statistically significant mean differences in bleeding on probing (BOP) increase were reported when comparing abutment materials (alumina and zirconia) with titanium [WMD = −9.35%]. However, comparing zirconia and titanium abutments separately (n = 3), a significant greater increase in BOP for titanium was reported [WMD = −26.96%;
| Plaque accumulation
Based on four randomized clinical trials, no statistically significant mean differences in plaque accumulation were reported when comparing abutment materials (alumina and zirconia) with titanium [WMD = −6.70%]. However, there was a trend for greater plaque accumulation at titanium compared to zirconia abutments [n = 1; MD = −20.00%; p = 0.068].
| What is the effect of abutment material on aesthetics?
The present systematic review was not able to detect any difference related to aesthetic outcomes among the abutment materials in terms of height of the interproximal papilla (n = 10 studies), colour of the mucosa (n = 1), or different aesthetic scores [Pink Aesthetic Score (PES; n = 2); Pink and White Aesthetic Score (n = 2), Implant Crown Aesthetic Index (ICAI; n = 3), Copenhagen Index Score (CIS; n = 2) or subjective professional evaluation (n = 2)].
Studies focusing on aesthetic outcomes, but not meeting the inclusion criteria of the present systematic review (Bressan, et al., 2011; Cosgarea, et al., 2015; Jung, et al., 2008; Linkevicius & Vaitelis, 2015; Martinez-Rus, et al., 2017; Sala, Bascones-Martinez, & Carrillo-de-Albornoz, 2017 ) reported statistically significant superiority of ceramic abutments over titanium abutments in developing natural soft tissue colour.
| What is the effect of abutment material on complications?
Based on 24 studies (13 RCTs, five CCTs, six case series) the total cumulative incidence of technical complications was 7.9%. In the controlled studies, the incidence of complications was slightly greater in the test groups than in the titanium groups (8.7% and 5.9%, respectively), but without statistically significant differences after a mean follow-up period of 30.76 months (range: 12-86 months), irrespective of the material used [n = 13; RR = 1.27]. Biological complications have been reported in 16 studies (six RCTs,three CCTs, seven cases series) showing a consistently low incidence of mucositis, peri-implantitis, fistulae and suppuration.
| What is the effect of new abutment materials on PROMs?
Patient-reported outcome measures (PROMs) were reported in 11 studies. Patients' aesthetic perception was evaluated by means of a visual analogue scale (VAS; five RCTs and one case series), by questionnaire (one RCTs, two CCTs, one case series) and one case series reported that all patients were satisfied with their restoration. In general, patients were highly satisfied with their implant-supported prosthesis and no differences could be attributed to abutment materials.
| CON CLUS IONS
Based on the present systematic review, the tested abutment materials can be considered appropriate for clinical use according to the observation period studied (mean 3.5 years).
| CLINIC AL RECOMMENDATIONS
Titanium has been the standard abutment material for many years and has been associated with stable marginal bone levels, high implant survival rates, healthy peri-implant tissues and a limited number of technical and biological complications. Therefore, titanium should be considered the material of choice for many clinical indications.
Of the alternative abutment materials, zirconia and alumina have been studied most frequently. These materials demonstrated similar biological effects to titanium in terms of marginal bone level changes, implant survival rates and peri-implant soft tissue parameters.
However, when compared with titanium abutments, zirconia abutments revealed lower plaque accumulation and bleeding on probing.
The choice of abutment material should be based on biological, technical and aesthetic aspects. Other factors, such as soft tissue thickness, implant site, economic concerns, etc. should be taken into consideration.
| What would be the most suitable abutment material to be used in clinical practice?
Abutment materials should demonstrate by appropriate scientific documentation:
• Reliable biocompatibility and stability.
• Easy manipulation and cost efficiency.
• Minimal incidence of biological and technical complications in the long term (success).
• Satisfying aesthetic demands.
| RECOMMENDATI ON FOR FUTURE RE S E ARCH
Future studies should address the following questions:
• what is the specific biological interaction between the abutment material and soft tissues.
• what is the impact of abutment processing and manipulation.
Future studies should investigate:
• New abutment materials should be adequately studied and documented before being introduced to the market for human use.
• Development of new abutment materials with proven antimicrobial properties.
• Development of new abutment materials with proven soft tissue integration.
| HOW DO PERI -IMPL ANT D IAG NOS TI C PAR AME TER S CORRE S P OND WITH LONG -TERM IMPL ANT SURVIVAL AND SUCCE SS
Implant dentistry today yields excellent long-term results in terms of implant survival, although this outcome may not necessarily reflect the health status of the peri-implant tissues nor the individual implant predictability. Focus on peri-implant diseases has increased in the last decade mainly due to their high prevalence, the lack of appropriate evidence-based guidelines for their treatment and the possible implications that these diseases may have on the outcome of the implant therapy.
One of the most controversial issues in current implant dentistry is the evidence-based knowledge on the prevalence of peri-implantitis, mainly due to the inconsistency of case definitions, case selection and the variability in diagnostic thresholds for disease. In the same way, there is debate on the diagnostic validity of probing depths and bleeding on probing, which has commonly been used to define periodontal diseases, but may not have the same diagnostic value to assess peri-implant tissue health and disease. It is therefore disputed whether these diagnostic parameters (probing depth and bleeding on probing) in conjunction with the evaluation of mean marginal bone loss correlate with the diagnosis of peri-implantitis.
It was therefore the aim of this review (Doornewaard, Jacquet, Cosyn, & De Bruyn, 2018) to evaluate the existing evidence of the correlation between peri-implantitis prevalence and:
• Mean Marginal Bone Loss (MBL).
• Mean Probing Depth (PD).
• Mean Bleeding on Probing (BOP).
| WHAT ARE THE D IAG NOS TI C PAR AME TER S MOS T FREQUENTLY US ED IN PERI -IMPL ANTITIS C A S E DEFINITIONS
Case definitions of peri-implantitis usually consist of composite evaluations of peri-implant tissue inflammation, either through bleeding on probing or bleeding scores and assessment of marginal bone loss with different thresholds ranging from <1 to >3 mm.
| HOW IS A C A S E OF PERI -IMPL ANTITIS DEFINED IN PRE VALEN CE S TUD IE S?
There is large variation in case definitions of peri-implantitis. Of 41 studies reporting prevalence of peri-implantitis, 15 lacked a case definition. The remaining 26 studies, applied 15 different definitions.
All case definitions, except one, included bleeding. Eight considered probing depth as changes or thresholds and eight considered suppuration. All case definitions included bone loss with eight applying a specific threshold for bone loss.
| IS THERE A CORREL ATI ON B E T WEEN ME AN PERI -IMPL ANT BONE LOSS AND THE PRE VALEN CE OF PERI -IMPL ANTITIS?
Weighted mean bone loss as reported in all 41 studies was 1.1 mm with a WMSD of 1.0 mm. Although the time point of baseline radiograph varied considerably. In 22 of 41 studies, baseline was considered after implant placement and in 19 at unspecified time points between placement and loading. From the studies (13) reporting mean values, SD and frequency distribution, bone loss was not normally distributed. Mean bone loss did not show any correlation with peri-implantitis prevalence. Of the studies reporting mean bone loss and standard deviations (37), it was estimated that the proportion of implants with bone loss exceeding 1, 2 and 3 mm would be 51%, 23% and 8%, respectively.
There is consensus that mean peri-implant bone loss is not an adequate outcome to study the prevalence of peri-implantitis, while the reporting of frequency distributions of sites with bone loss exceeding internationally accepted thresholds is considered more appropriate.
| IS THERE A CORREL ATI ON B E T WEEN ME AN PERI -IMPL ANT B LEED ING SCORE S AND THE PRE VALEN CE OF PERI -IMPL ANTITIS?
Mean values of peri-implant bleeding scores were reported in 24 studies. Weighted Mean BOP was 52%, ranging from 5%-95%.
Mean BOP did not show any correlation with peri-implantitis prevalence. There is consensus that mean peri-implant bleeding scores is not an adequate outcome to study peri-implantitis, while the reporting of frequency distributions of sites demonstrating inflammation disclosed by bleeding on probing is considered more appropriate.
| IS THERE A CORREL ATI ON B E T WEEN ME AN PERI -IMPL ANT PROB ING DEP TH AND THE PRE VALEN CE OF PERI -IMPL ANTITIS?
Mean values of peri-implant probing depth were reported in 25 studies. Weighted mean PD was 3.3 mm, ranging from 2.2-4.3 mm.
Only one study reported a mean value exceeding 4 mm. Mean PD does not correlate with prevalence of peri-implantitis, nor with mean bone loss. There is consensus that mean peri-implant probing depth is not an adequate outcome to study the prevalence of peri-implantitis, while the reporting of frequency distributions of sites with deep probing depths exceeding internationally accepted thresholds is considered more appropriate. 
| FUTURE RE S E ARCH D IREC TI ON S
Using currently available diagnostic tools, reporting mean/median values of diagnostic parameters, is not sufficient per se to describe the extent of biological complications in epidemiological research.
Future studies should also clearly report:
• Case definitions (internationally accepted).
• Validated assessments (repeated measurements, calibrated examiners).
• Baseline registrations (PD, BOP and MB levels).
• Frequency distributions combining the different diagnostic parameters.
• Percentage of disease according to case definition, based on patient and implant level.
We foresee the importance of the development of new diagnostic tools with improved sensitivity and specificity to assess changes in MB levels and distinguish between health and diseased peri-implant soft tissues.
O RCI D
Mariano Sanz
http://orcid.org/0000-0002-6293-5755
Bjorn Klinge http://orcid.org/0000-0003-2100-2446
Jan Derks http://orcid.org/0000-0002-1133-6074
